Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2684

Actual shortage: 240 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2435 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2020-04-02 2020-05-14 110685
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2020-12-03 2020-12-03 129512
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2021-02-05 2021-03-04 133441
TEVA-DILTIAZEM XC 180MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-16 2023-04-28 184919
TEVA-DILTIAZEM XC 180MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-12 2023-12-07 206904
TEVA-METHYLPHENIDATE ER-C 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-11-24 2020-01-21 30668
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
TEVA-ATOMOXETINE 18MG CAPSULE Resolved 2020-04-02 2021-04-15 110670
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2017-03-13 2020-02-13 1697
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2017-03-13 2021-09-23 1714
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2019-06-18 2019-07-15 86972
CEFOXITIN FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2019-06-27 2020-02-07 87662
TEVA-SUCRALFATE 1G TABLET Resolved 2019-08-29 2020-01-30 92663
CEFAZOLIN FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2019-09-26 2019-10-10 94837
TEVA-TRYPTOPHAN 1G TABLET Resolved 2020-02-07 2020-03-26 105564
TEVA-SUCRALFATE 1G TABLET Resolved 2020-03-26 2020-08-21 109595
TEVA-SUCRALFATE 1G TABLET Resolved 2020-07-23 2020-08-21 120890
TEVA-SUCRALFATE 1G TABLET Resolved 2020-09-24 2020-10-15 124995
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2021-01-07 2021-02-12 131093

Showing 901 to 920 of 2684

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917

Showing 21 to 40 of 250